Cargando…
Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer
BACKGROUND: Recent data suggest that human epidermal growth factor receptor 2 (HER2)-low breast cancer may represent a distinct entity. We aimed to compare disease characteristics and outcomes between HER2-low and HER2-0 in estrogen receptor (ER) positive, early-stage breast cancer. METHODS: A singl...
Autores principales: | Mutai, Raz, Barkan, Tamar, Moore, Assaf, Sarfaty, Michal, Shochat, Tzippy, Yerushalmi, Rinat, Stemmer, Salomon M., Goldvaser, Hadar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414540/ https://www.ncbi.nlm.nih.gov/pubmed/34481367 http://dx.doi.org/10.1016/j.breast.2021.08.016 |
Ejemplares similares
-
The impact of endogenous estrogen exposures on the characteristics and outcomes of estrogen receptor positive, early breast cancer
por: Korzets, Yasmin, et al.
Publicado: (2021) -
The concordance of treatment decision guided by OncotypeDX and the PREDICT tool in real‐world early‐stage breast cancer
por: Goldstein, Daniel A., et al.
Publicado: (2020) -
Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis
por: Reinhorn, Daniel, et al.
Publicado: (2021) -
Deescalating Adjuvant Trastuzumab in HER2-Positive Early-Stage Breast Cancer: A Systemic Review and Meta-Analysis
por: Goldvaser, Hadar, et al.
Publicado: (2019) -
COVID-19 in a patient receiving adjuvant breast cancer chemotherapy with granulocyte olony-stimulating factor (G-CSF) support: A case report
por: Yerushalmi, Rinat, et al.
Publicado: (2021)